Published in Cochrane Database Syst Rev on July 07, 2010
The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharm (2013) 1.41
The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30
Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol (2012) 1.26
Paying pharmacists for patient care: A systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott) (2014) 1.24
Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health (2012) 1.09
Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott) (2013) 1.04
Effects of prescription adaptation by pharmacists. BMC Health Serv Res (2010) 1.03
Older patient, physician and pharmacist perspectives about community pharmacists' roles. Int J Pharm Pract (2012) 1.02
The expanding scope of pharmacists' practice: implications for physicians. CMAJ (2013) 1.01
Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey. Pharm Pract (Granada) (2012) 0.97
A cluster randomised controlled trial of a pharmacist-led collaborative intervention to improve statin prescribing and attainment of cholesterol targets in primary care. PLoS One (2014) 0.93
Prescription of potentially inappropriate medication in older persons in Switzerland: does the dispensing channel make a difference? Risk Manag Healthc Policy (2015) 0.91
Medication reviews for nursing home residents to reduce mortality and hospitalization: systematic review and meta-analysis. Br J Clin Pharmacol (2014) 0.90
Under the same roof: co-location of practitioners within primary care is associated with specialized chronic care management. BMC Fam Pract (2014) 0.87
Opti-Med: the effectiveness of optimised clinical medication reviews in older people with 'geriatric giants' in general practice; study protocol of a cluster randomised controlled trial. BMC Geriatr (2014) 0.85
Patient participation in medication reviews is desirable but not evidence-based: a systematic literature review. Br J Clin Pharmacol (2014) 0.84
Effect evaluation of an interprofessional medication therapy management approach for multimorbid patients in primary care: a cluster-randomized controlled trial in community care (WestGem study protocol). BMC Fam Pract (2015) 0.82
What patients think doctors know: beliefs about provider knowledge as barriers to safe medication use. Patient Educ Couns (2013) 0.81
A cost-effectiveness analysis of an in-hospital clinical pharmacist service. BMJ Open (2012) 0.81
Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in Vienna. J Pharm Policy Pract (2014) 0.80
Counselling practices in community pharmacies in Riyadh, Saudi Arabia: a cross-sectional study. BMC Health Serv Res (2015) 0.80
Nurse-Led Medicines' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial. PLoS One (2015) 0.79
Twelve-month prospective randomized study of pharmacists utilizing point-of-care testing for metabolic syndrome and related conditions in subjects prescribed antipsychotics. Prim Care Companion CNS Disord (2014) 0.79
A centralized cardiovascular risk service to improve guideline adherence in private primary care offices. Contemp Clin Trials (2015) 0.78
A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence. Pharmacotherapy (2015) 0.78
Adherence counseling during patient contacts in swiss community pharmacies. Patient Prefer Adherence (2015) 0.78
General practitioners' perceptions of the current status and pharmacists' contribution to primary care in Iceland. Int J Clin Pharm (2017) 0.78
Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial. Eur J Clin Pharmacol (2017) 0.78
High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved? Ther Adv Drug Saf (2012) 0.77
Improving critical care discharge summaries: a collaborative quality improvement project using PDSA. BMJ Qual Improv Rep (2015) 0.77
Patient-specific academic detailing for smoking cessation: feasibility study. Can Fam Physician (2014) 0.76
Coping strategies used by patients infected with hepatitis C virus who are facing medication costs. Can J Hosp Pharm (2011) 0.76
Has hospital pharmacy passed its peak? Can J Hosp Pharm (2013) 0.75
Adaptation and validation of a questionnaire assessing patient satisfaction with pharmacy services in general hospitals. Patient Prefer Adherence (2014) 0.75
Evaluation of counseling environmental alteration on pharmacy-patient communication qualifications: A case-control study. Medicine (Baltimore) (2016) 0.75
Political advocacy in pharmacy: challenges and opportunities. Integr Pharm Res Pract (2015) 0.75
Do community pharmacists actively engage elderly patients in the dialogue? Results from pharmaceutical care consultations. Health Expect (2013) 0.75
A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial. Pharm Pract (Granada) (2015) 0.75
Implementing an online pharmaceutical service using design science research. BMC Med Inform Decis Mak (2017) 0.75
An introduction to the fundamentals of randomized controlled trials in pharmacy research. Can J Hosp Pharm (2015) 0.75
The iMpact on practice, oUtcomes and costs of New roles for health pROfeSsionals: a study protocol for MUNROS. BMJ Open (2016) 0.75
Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials. PLoS One (2014) 0.75
Assessing Medicare Beneficiary Eligibility for Medication Therapy Management Programs Using PINNACLE, a National Cardiovascular Data Registry. Am Health Drug Benefits (2013) 0.75
What works for whom in pharmacist-led smoking cessation support: realist review. BMC Med (2016) 0.75
Maintenance of Goal Blood Pressure, Cholesterol, and A1C Levels in Veterans With Type 2 Diabetes After Discharge From a Pharmacist-Managed Ambulatory Care Clinic. Diabetes Spectr (2015) 0.75
Self-reported and actual involvement of community pharmacists in patient counseling: a cross-sectional and simulated patient study in Gondar, Ethiopia. Pharm Pract (Granada) (2017) 0.75
Do Pharmacists Have a Role in Recommending Codeine for Pain Management? Australian Perspectives. Can J Hosp Pharm (2016) 0.75
Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study. BMC Health Serv Res (2017) 0.75
Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden. Drugs Real World Outcomes (2017) 0.75
Introducing Pharmaceutical Care to Primary Care in Iceland-An Action Research Study. Pharmacy (Basel) (2017) 0.75
A Pilot Project for Clinical Pharmacy Services in a Clinic for Children With Medical Complexity. J Pediatr Pharmacol Ther (2017) 0.75
Industry sponsorship and research outcome. Cochrane Database Syst Rev (2012) 7.44
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell (2008) 5.37
Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med (2009) 5.15
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med (2008) 3.57
The direct cost and incidence of systemic fungal infections. Value Health (2002) 2.64
K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell (2010) 2.52
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med (2013) 2.49
Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA (2002) 2.43
Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev (2005) 2.38
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect (2013) 2.21
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev (2014) 2.10
Simulated patients in the community pharmacy setting. Using simulated patients to measure practice in the community pharmacy setting. Pharm World Sci (2004) 2.05
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nat Chem Biol (2010) 1.94
Engineering and structural characterization of a linear polyubiquitin-specific antibody. J Mol Biol (2011) 1.93
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood (2007) 1.73
Preferences for self-care or professional advice for minor illness: a discrete choice experiment. Br J Gen Pract (2006) 1.68
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ (2012) 1.58
Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs. Hum Mol Genet (2009) 1.53
CONSORT 2010. Lancet (2010) 1.50
Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell (2010) 1.41
Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med (2013) 1.39
Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland. J Public Health (Oxf) (2007) 1.38
Is it me or is it them? Factors that influence the passing of underperforming students. Med Educ (2008) 1.35
Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol (2012) 1.28
Exploring patients' perspectives of pharmacist supplementary prescribing in Scotland. Pharm World Sci (2008) 1.28
Reflective interferometric fourier transform spectroscopy: a self-compensating label-free immunosensor using double-layers of porous SiO2. J Am Chem Soc (2006) 1.27
Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother (2006) 1.23
Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19
Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials (2009) 1.19
Are pharmacy-based minor ailment schemes a substitute for other service providers? A systematic review. Br J Gen Pract (2013) 1.19
Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation. Int J Pharm Pract (2009) 1.17
Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial. BMJ Open (2013) 1.16
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev (2013) 1.12
Preparation of distinct ubiquitin chain reagents of high purity and yield. Structure (2011) 1.11
Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (2013) 1.07
Evolving cardiovascular disease prevalence, mortality, risk factors, and the metabolic syndrome in China. Clin Cardiol (2009) 1.07
An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements. J Biol Chem (2004) 1.06
Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health (2012) 1.05
Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf (2011) 1.04
Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab (2003) 1.04
Public knowledge, attitudes and behaviour regarding antibiotics--a survey of patients in general practice. Eur J Gen Pract (2003) 1.02
Simulated patient visits with immediate feedback to improve the supply of over-the-counter medicines: a feasibility study. Fam Pract (2009) 0.99
The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist. Fam Pract (2005) 0.99
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals. Drug Saf (2010) 0.98
Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutr (2009) 0.98
Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service. Int J Pharm Pract (2011) 0.97
Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling. Science (2013) 0.95
Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing. Ann Pharmacother (2009) 0.93
Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med (2009) 0.93
Pharmacy customers' views and experiences of using pharmacies which provide drug misuse services. Drug Alcohol Rev (2004) 0.92
Exploring the supply of non-prescription medicines from community pharmacies in Scotland. Pharm World Sci (2008) 0.92
Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci (2007) 0.90
Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC). Pharm World Sci (2003) 0.89
Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev (2013) 0.88
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr (2012) 0.87
Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One (2009) 0.86
Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells. Biochem Pharmacol (2007) 0.84
Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab (2013) 0.84
Effectiveness of theory-based invitations to improve attendance at cardiac rehabilitation: a randomized controlled trial. Eur J Cardiovasc Nurs (2013) 0.83
Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine Tob Res (2007) 0.83
Interactions between non-physician clinicians and industry: a systematic review. PLoS Med (2013) 0.83
Is treatment with 6-mercaptopurine for colitis associated with the development of colorectal cancer? Inflamm Bowel Dis (2013) 0.83
Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model. Bioorg Med Chem Lett (2006) 0.82
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutation. J Med Chem (2014) 0.82
Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC Health Serv Res (2012) 0.81
Review of the quality of pediatric medications in developing countries. J Pharm Sci (2013) 0.81
Views of pharmacists and mentors on experiential learning for pharmacist supplementary prescribing trainees. Pharm World Sci (2007) 0.80
Experiential learning as part of pharmacist supplementary prescribing training: feedback from trainees and their mentors. Ann Pharmacother (2007) 0.80
Novel 5-azaindole factor VIIa inhibitors. Bioorg Med Chem Lett (2006) 0.79
Could chiropractors screen for adverse drug events in the community? Survey of US chiropractors. Chiropr Osteopat (2010) 0.79
Theory-based communication skills training for medicine counter assistants to improve consultations for non-prescription medicines. Med Educ (2007) 0.79
A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev (2014) 0.78
Electronic screening of medical records to detect inpatients at risk of drug-related problems. Pharm World Sci (2009) 0.78
The effect of an internet option and single-sided printing format to increase the response rate to a population-based study: a randomized controlled trial. BMC Med Res Methodol (2014) 0.78
Factor VIIa inhibitors: gaining selectivity within the trypsin family. Bioorg Med Chem Lett (2006) 0.77
Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab (2012) 0.77
Discovery of novel heterocyclic factor VIIa inhibitors. Bioorg Med Chem Lett (2006) 0.77
Using the theory of planned behaviour to develop targets for interventions to enhance patient communication during pharmacy consultations for non-prescription medicines. Int J Pharm Pract (2014) 0.77
Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial. Int J Pharm Pract (2013) 0.77
Views of parents and pharmacists following participation in a paediatric pharmacovigilance study. Pharm World Sci (2010) 0.77
Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev (2015) 0.77
Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychother Psychosom (2017) 0.76
Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study. J Med Chem (2015) 0.76
Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study. Pharm World Sci (2003) 0.76
Systematic reviews: perhaps "the answer to policy makers' prayers"? Environ Health Perspect (2014) 0.75
pH-triggered release of macromolecules from spray-dried polymethacrylate microparticles. Pharm Res (2003) 0.75
Clarification of study and citation. Arch Intern Med (2007) 0.75
Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environ Health Perspect (2014) 0.75
Correction to Noncovalent Mutant Selective Epidermal Growth Factor Receptor Inhibitors: A Lead Optimization Case Study. J Med Chem (2016) 0.75
Needs assessment study for community pharmacy travel medicine services. J Travel Med (2008) 0.75
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor. J Med Chem (2016) 0.75
From the literature. Aust Endod J (2016) 0.75
Adherence: the Holy Grail? BMJ Qual Saf (2016) 0.75
Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evid Synth (2020) 0.75
The Cochrane Library Oversight Committee. Cochrane Database Syst Rev (2011) 0.75
P450c17 deficiency caused by compound heterozygosity for two novel mutations presenting as hypotension in early infancy. Horm Res Paediatr (2011) 0.75
Discovery of novel hydroxy pyrazole based factor IXa inhibitor. Bioorg Med Chem Lett (2006) 0.75
Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. Int J Pharm Pract (2010) 0.75
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev (2016) 0.75